Blogger sued by pharma firm for the first time in India

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juri...Read more

Actavis sets up APAC headquarter in Singapore

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Apr, 2014

Singapore: Global generics firm, Actavis, has opened its regional office in Singapore that will serve as the headquarter...Read more

Indian regulator cracks down on banned drugs

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Jan, 2013

Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the count...Read more

Why Mylan sued US FDA over Diovan generic?

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic...Read more

Ranbaxy now recalls 64,000 bottles of generic heart drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2014

Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehension...Read more

APAC Epilepsy Therapeutics market to touch $1.5 bn by 2019

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 28 Feb, 2014

Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...Read more

Pfizer, Mylan settle litigation over Detrol LA generic

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 10 Sep, 2012

Singapore: Pfizer has settled its litigation against Mylan and Mylan Pharmaceuticals relating to Pfizer's patents coveri...Read more

Mundipharma, Horizon subsidiary sign arthritis deal

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 13 Nov, 2013

Singapore: Mundipharma has signed an exclusive agreement with the Swiss subsidiary of Horizon Pharma for the commerciali...Read more

Aurobindo diabetes generic gets US FDA nod

Generics |  Regulatory | By BioSpectrum Bureau  | 3 Comment | 04 Feb, 2014

Singapore: Aurobindo Pharma has received US FDA approval for Repaglinide tablets, the generic equivalent of Novo Nordisk...Read more

Patents worth $60 billion set to expire by 2019

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2012

The year 2012 has brought a world of opportunities for Indian biotech companies, with big-wig biotech firms in the West ...Read more

Cipla nurtures global vision for affordable drugs

Generics |  Analysis | By BioSpectrum Bureau  | 2 Comment | 13 Jun, 2012

The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...Read more

Gilead allows sublicense of HIV drug to generic firms

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2014

Singapore: HIV drug developer, Gilead Sciences has partnered with Medicines Patent Pool (MPP) to expand access to Gilead...Read more

Bayer plea for stay on compulsory license dismissed

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

Bangalore: The Intellectual Property Appellate Board in Chennai, India, has rejected pharma major Bayer's petition seeki...Read more

Perrigo rejects Mylan's acquisition bid

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 28 Apr, 2015

Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....Read more

Ranbaxy, Lundbeck face EU fury for blocking generics

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

Singapore: The European Commission (EC) is going to fine seven generic drug firms, including India-based Ranbaxy and Den...Read more

FDA flags GMP issues at Impax's Taiwan facility

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2014

Singapore: Regulatory hurdles continue to haunt Impax Laboratories and its experimental drug, Rytary, that treats idiopa...Read more

Lupin gets FDA nod to make generic insomnia drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2013

Singapore: The US FDA provided its final approval to Indian drug maker Lupin to manufacture and market a generic version...Read more

Aurobindo Pharma files ANDA for HIV generic drug

Generics |  News | By BioSpectrum Bureau  | 0 Comment | 27 May, 2015

Singapore: India's Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for ...Read more